首页> 美国卫生研究院文献>PLoS Clinical Trials >Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods
【2h】

Quantifying uncertainty about future antimicrobial resistance: Comparing structured expert judgment and statistical forecasting methods

机译:量化关于未来抗药性的不确定性:比较结构化专家判断和统计预测方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The increase of multidrug resistance and resistance to last-line antibiotics is a major global public health threat. Although surveillance programs provide useful current and historical information on the scale of the problem, the future emergence and spread of antibiotic resistance is uncertain, and quantifying this uncertainty is crucial for guiding decisions about investment in antibiotics and resistance control strategies. Mathematical and statistical models capable of projecting future rates are challenged by the paucity of data and the complexity of the emergence and spread of resistance, but experts have relevant knowledge. We use the Classical Model of structured expert judgment to elicit projections with uncertainty bounds of resistance rates through 2026 for nine pathogen-antibiotic pairs in four European countries and empirically validate the assessments against data on a set of calibration questions. The performance-weighted combination of experts in France, Spain, and the United Kingdom projected that resistance for five pairs on the World Health Organization’s priority pathogens list (E. coli and K. pneumoniae resistant to third-generation cephalosporins and carbapenems and MRSA) would remain below 50% in 2026. In Italy, although upper bounds of 90% credible ranges exceed 50% resistance for some pairs, the medians suggest Italy will sustain or improve its current rates. We compare these expert projections to statistical forecasts based on historical data from the European Antimicrobial Resistance Surveillance Network (EARS-Net). Results from the statistical models differ from each other and from the judgmental forecasts in many cases. The judgmental forecasts include information from the experts about the impact of current and future shifts in infection control, antibiotic usage, and other factors that cannot be easily captured in statistical forecasts, demonstrating the potential of structured expert judgment as a tool for better understanding the uncertainty about future antibiotic resistance.
机译:多药耐药性和对最后一线抗生素的耐药性增加是全球主要的公共卫生威胁。尽管监视程序可以提供有关问题规模的有用的当前和历史信息,但是抗生素耐药性的未来出现和传播尚不确定,而量化这种不确定性对于指导有关抗生素投资和耐药性控制策略的决策至关重要。能够预测未来利率的数学和统计模型受到数据的匮乏以及阻力出现和扩散的复杂性的挑战,但是专家们具有相关知识。我们使用结构化专家判断的经典模型,得出了四个欧洲国家中9个病原体-抗生素对在2026年之前的耐药率不确定范围的预测,并根据一组校准问题的数据进行了经验验证。法国,西班牙和英国的专家对绩效进行加权评估后,预计世界卫生组织的优先病原体清单中有五对细菌耐药(对第三代头孢菌素,碳青霉烯和MRSA耐药的大肠杆菌和肺炎克雷伯菌)到2026年仍将维持在50%以下。在意大利,尽管某些货币对的90%可信区间的上限超过了50%阻力,但中位数表明意大利将维持或提高其当前汇率。我们将这些专家预测与基于欧洲抗菌素耐药性监测网络(EARS-Net)的历史数据的统计预测进行比较。统计模型的结果彼此不同,并且在许多情况下与判断预测也不同。判断性预测包括专家提供的有关感染控制方面当前和未来变化,抗生素使用以及统计预测中无法轻易捕捉到的其他因素的影响的信息,这表明结构化专家判断作为更好地了解不确定性的工具的潜力关于未来的抗生素耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号